Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
NCT05593055Phase 4Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2023
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Brigham and Women's Hospital. Started Aug 2023; status: recruiting.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT05593055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05593055.